Altimmune Cash And Short Term Investments from 2010 to 2025
| ALT Stock | USD 5.81 0.20 3.57% |
Cash And Short Term Investments | First Reported 2005-06-30 | Previous Quarter 139.4 M | Current Value 131.9 M | Quarterly Volatility 75.5 M |
Check Altimmune financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Altimmune's main balance sheet or income statement drivers, such as Interest Expense of 8.6 K, Selling General Administrative of 14 M or Total Revenue of 19 K, as well as many indicators such as Price To Sales Ratio of 26.9 K, Dividend Yield of 0.0 or PTB Ratio of 4.35. Altimmune financial statements analysis is a perfect complement when working with Altimmune Valuation or Volatility modules.
Altimmune | Cash And Short Term Investments |
Latest Altimmune's Cash And Short Term Investments Growth Pattern
Below is the plot of the Cash And Short Term Investments of Altimmune over the last few years. Short Term Investments is an account in the current assets section of Altimmune balance sheet. This account contains Altimmune investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Altimmune fairly quickly. It is the sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash. Altimmune's Cash And Short Term Investments historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Altimmune's overall financial position and show how it may be relating to other accounts over time.
| Cash And Short Term Investments | 10 Years Trend |
|
Cash And Short Term Investments |
| Timeline |
Altimmune Cash And Short Term Investments Regression Statistics
| Arithmetic Mean | 85,472,989 | |
| Geometric Mean | 38,393,671 | |
| Coefficient Of Variation | 102.35 | |
| Mean Deviation | 78,597,262 | |
| Median | 37,240,072 | |
| Standard Deviation | 87,485,036 | |
| Sample Variance | 7653.6T | |
| Range | 219.4M | |
| R-Value | 0.64 | |
| Mean Square Error | 4860.9T | |
| R-Squared | 0.41 | |
| Significance | 0.01 | |
| Slope | 11,726,305 | |
| Total Sum of Squares | 114804.5T |
Altimmune Cash And Short Term Investments History
About Altimmune Financial Statements
Altimmune shareholders use historical fundamental indicators, such as Cash And Short Term Investments, to determine how well the company is positioned to perform in the future. Although Altimmune investors may analyze each financial statement separately, they are all interrelated. The changes in Altimmune's assets and liabilities, for example, are also reflected in the revenues and expenses on on Altimmune's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Cash And Short Term Investments | 131.9 M | 76.2 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Altimmune Stock Analysis
When running Altimmune's price analysis, check to measure Altimmune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Altimmune is operating at the current time. Most of Altimmune's value examination focuses on studying past and present price action to predict the probability of Altimmune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Altimmune's price. Additionally, you may evaluate how the addition of Altimmune to your portfolios can decrease your overall portfolio volatility.